Literature DB >> 16293178

WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects.

Günter Burg1, Werner Kempf, Antonio Cozzio, Josef Feit, Rein Willemze, Elaine S Jaffe, Reinhard Dummer, Emilio Berti, Lorenzo Cerroni, Sergio Chimenti, José L Diaz-Perez, Florent Grange, Nancy L Harris, Dmitry V Kazakov, Helmut Kerl, Michael Kurrer, Robert Knobler, Chris J L M Meijer, Nicola Pimpinelli, Elisabeth Ralfkiaer, Robin Russell-Jones, Christian Sander, Marco Santucci, Wolfram Sterry, Steven H Swerdlow, Maarten H Vermeer, Janine Wechsler, Sean Whittaker.   

Abstract

UNLABELLED: The new WHO/EORTC classification for cutaneous lymphomas comprises mature T-cell and natural killer (NK)-cell neoplasms, mature B-cell neoplasms, and immature hematopoietic malignancies. It reflects the unique features of lymphoproliferative diseases of the skin, and at the same time it is as compatible as possible with the concepts underlying the WHO classification for nodal lymphomas and the EORTC classification of cutaneous lymphomas. This article reviews the histological, phenotypical, and molecular genetic features of the various nosological entities included in this new classification. These findings always have to be interpreted in the context of the clinical features and biologic behavior. AIM: To review the histological, phenotypical and molecular genetic features of the various nosological entities of the new WHO/EORTC classification for cutaneous lymphomas.
METHODS: Extensive review of the literature cited in Medline and own data of the authors.
RESULTS: The WHO/EORTC classification of cutaneous lymphomas comprises mature T-cell and NK-cell neoplasms, mature B-cell neoplasms and immature hematopoietic malignancies. It reflects the unique features of primary cutaneous lymphoproliferative diseases.
CONCLUSION: This classification is as much as possible compatible with the concept of the WHO classification for nodal lymphomas and the EORTC classification of cutaneous lymphomas. The histological, phenotypical and molecular genetic features always have to be interpreted in the context of the clinical features and biologic behavior.

Entities:  

Mesh:

Year:  2005        PMID: 16293178     DOI: 10.1111/j.0303-6987.2005.00495.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  34 in total

Review 1.  [The role of molecular genetics in dermatologic diagnosis].

Authors:  M Braun-Falco; T Ruzicka
Journal:  Hautarzt       Date:  2012-04       Impact factor: 0.751

2.  Epidermoid cyst mimicry: report of seven cases and review of the literature.

Authors:  Jorge Garcia-Zuazaga; Malcolm S Ke; Marlene Willen
Journal:  J Clin Aesthet Dermatol       Date:  2009-10

3.  The High Expression of the microRNA 17-92 Cluster and its Paralogs, and the Downregulation of the Target Gene PTEN, Is Associated with Primary Cutaneous B-Cell Lymphoma Progression.

Authors:  Maxime Battistella; Martha Romero; Luis-Jaime Castro-Vega; Guillaume Gapihan; Fatiha Bouhidel; Martine Bagot; Jean-Paul Feugeas; Anne Janin
Journal:  J Invest Dermatol       Date:  2015-01-29       Impact factor: 8.551

Review 4.  The histological classification of diffuse large B-cell lymphomas.

Authors:  Yi Xie; Stefania Pittaluga; Elaine S Jaffe
Journal:  Semin Hematol       Date:  2015-01-17       Impact factor: 3.851

5.  [NK/T-cell lymphoma, nasal type with cutaneous dissemination].

Authors:  A M Baran; J Reifenberger; D Helbig
Journal:  Hautarzt       Date:  2012-04       Impact factor: 0.751

6.  Intraocular involvement of mycosis fungoides associated with immunophenotypic switch from CD4+ to CD8<sup/>.

Authors:  Jonathan A Braue; Anthony B Daniels; Jeffrey P Zwerner; Stephen J Kim; John A Zic
Journal:  Blood       Date:  2018-01-03       Impact factor: 22.113

7.  Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL).

Authors:  Ulrik Ralfkiaer; Peter H Hagedorn; Nannie Bangsgaard; Marianne B Løvendorf; Charlotte B Ahler; Lars Svensson; Katharina L Kopp; Marie T Vennegaard; Britt Lauenborg; John R Zibert; Thorbjørn Krejsgaard; Charlotte M Bonefeld; Rolf Søkilde; Lise M Gjerdrum; Tord Labuda; Anne-Merete Mathiesen; Kirsten Grønbæk; Mariusz A Wasik; Malgorzata Sokolowska-Wojdylo; Catherine Queille-Roussel; Robert Gniadecki; Elisabeth Ralfkiaer; Carsten Geisler; Thomas Litman; Anders Woetmann; Christian Glue; Mads A Røpke; Lone Skov; Niels Odum
Journal:  Blood       Date:  2011-08-24       Impact factor: 22.113

8.  Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell Lymphoma.

Authors:  Salvia Jain; Abigail Washington; Rebecca Karp Leaf; Parul Bhargava; Rachael A Clark; Thomas S Kupper; Dina Stroopinsky; Athalia Pyzer; Leandra Cole; Myrna Nahas; Arie Apel; Jacalyn Rosenblatt; Jon Arnason; Donald Kufe; David Avigan
Journal:  Mol Cancer Ther       Date:  2017-07-20       Impact factor: 6.261

9.  Granulomatous slack skin. Histopathology diagnosis preceding clinical manifestations by 12 years.

Authors:  Karen O Goldsztajn; Beatriz Moritz Trope; Maria Elisa Ribeiro Lenzi; Tullia Cuzzi; Marcia Ramos-E-Silva
Journal:  J Dermatol Case Rep       Date:  2012-12-31

Review 10.  The histological and biological spectrum of diffuse large B-cell lymphoma in the World Health Organization classification.

Authors:  Madhu P Menon; Stefania Pittaluga; Elaine S Jaffe
Journal:  Cancer J       Date:  2012 Sep-Oct       Impact factor: 3.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.